Recruitment, risks, rewards, and regrets : senior researcher reflections on working with alcohol industry social aspects organisations by Mitchell, Gemma & McCambridge, Jim
This is a repository copy of Recruitment, risks, rewards, and regrets : senior researcher 
reflections on working with alcohol industry social aspects organisations.




Mitchell, Gemma orcid.org/0000-0003-0199-859X and McCambridge, Jim orcid.org/0000-
0002-5461-7001 (2021) Recruitment, risks, rewards, and regrets : senior researcher 
reflections on working with alcohol industry social aspects organisations. Drug and Alcohol





This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Recruitment, risks, rewards and regrets: Senior researcher
reflections on working with alcohol industry social aspects
organisations
GEMMA MITCHELL & JIM MCCAMBRIDGE
Department of Health Sciences, University of York, York, UK
Abstract
Introduction. A growing body of literature suggests alcohol industry corporate social responsibility activity, including the cre-
ation of ‘social aspects’ organisations (SAO), may harm rather than improve public health. We aimed to explore established
researcher experiences of working with SAOs, and the factors informing their decisions to do so. Methods. Qualitative inter-
view study with senior alcohol researchers who had previous or ongoing connections to SAOs or their predecessors initiated
when their careers were established (n = 16). Thematic analysis using NVivo software. Results. Established researchers were
recruited for their expertise by alcohol industry SAOs via employees who were previously academics or via academic colleagues
with SAO connections. Motivated by the desire to improve public health and ‘reach out’ beyond academia, researchers were
confident that they could maintain their independence when sharing their expertise with SAOs. Short-term connections
included attendance at SAO-funded events and book chapter contributions. Sometimes, these led to long-term relationships
with SAOs, or researchers were invited to long-term roles by a colleague. These included memberships of scientific advisory
committees, board positions, or work as independent consultants. Most researchers reflected negatively on their experiences and
had ended their associations, while some had positive experiences. Discussion and Conclusion. Current and former
researchers play key roles in initiating connections with SAOs, with industry-funded events and invitations to long-term roles
by trusted colleagues, mechanisms used to facilitate the development of such relationships. Our study adds to existing evidence
that SAO scientific activity does not contribute to public health goals, but does present industry with public relations
opportunities. [Mitchell G, McCambridge J. Recruitment, risks, rewards and regrets: Senior researcher reflections on
working with alcohol industry social aspects organisations. Drug Alcohol Rev 2021]
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Introduction
Public Health England partnered with the alcohol
industry ‘social aspects’ organisation (SAO)
Drinkaware on a ‘Drink Free Days’ campaign in 2018
[1], following a well-worn industry strategy of defining
alcohol problems in terms of the minority of individ-
uals who drink heavily, in this case daily [2]. Such con-
troversies regarding partnerships between alcohol
industry and public health organisations are perennial
because the public health community fails to under-
stand the advanced nature of alcohol industry political
strategies [3] and their success in influencing national
governments and government agencies [4].
Alcohol industry SAOs include organisations such
as Drinkaware, as well as industry research funding
organisations such as the European Research Advisory
Board. SAOs are a discrete type of corporate social
responsibility (CSR) activity that overlaps with other
forms of CSR, including alcohol information and edu-
cation provision; drink driving prevention; research
involvement; and policy involvement [5]. Ostensibly,
alcohol industry SAOs exist to reduce the harm caused
by the consumption of alcohol. A recent systematic
review, however, found little evidence supporting the
effectiveness of CSR activities in terms of improving
public health [5]. Numerous studies, including several
published subsequently, find that such initiatives may
do the opposite through, for example, misinformation
to the public [6–8]; the maintenance of social norms
that support commercial, rather than public health
interests [9–11]; and using CSR activities as forms of
Gemma Mitchell PhD, Research Fellow, Jim McCambridge Professor PhD, Chair in Addictive Behaviours and Public Health. Correspondence
to: Dr Gemma Mitchell Department of Health Sciences, Seebohm Rowntree Building, University of York, Heslington, York, YO10 5DD,
UK. Tel: 01904 328607; E-mail: gemma.mitchell@york.ac.uk
Received 16 December 2020; accepted for publication 30 May 2021.
R E V I E W
Drug and Alcohol Review (2021)
DOI: 10.1111/dar.13342
© 2021 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other
Drugs.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
indirect marketing [5]. SAOs such as Drinkaware nev-
ertheless make strong claims that their activities are
supported by scientific evidence, and they recruit med-
ical and scientific colleagues for this purpose [12–14].
A prominent example of an alcohol industry SAO is
the (now replaced) International Center for Alcohol
Policies (ICAP), which operated in research and policy
at the global level and in high, middle, and low-income
countries [5]. ICAP was founded in 1995 by 10 of the
world’s largest beer and spirits companies at the time,
with one of those 10 alcohol companies, Miller
Brewing, at that time owned by tobacco giant Philip
Morris [15]. Much ICAP activity appears specifically
designed to counter the work of the World Health
Organization, and it recruited an academic and former
World Health Organization employee as its Director
[15]. From its inception, it promoted ‘partnership’
between industry and public health. To support efforts
at influencing policy, the organisation was active in sci-
ence, initiating the formation of the ‘Dublin Principles’,
a set of guidelines aimed at encouraging partnership
between the research community and industry [16].
ICAP also recruited academics and other public health
actors to aid the creation of a ‘grey’ literature parallel to
peer-reviewed research on alcohol [15]. This literature
was distinguished by what it excluded, notably the role
of industry in perpetuating alcohol harms, and
emphasised uncertainty about effective population-based
approaches that would reduce corporate profits [15,17].
Following a merger of ICAP and the Global Alcohol
Producers Group in late 2014, ICAP was replaced by
the International Alliance for Responsible Drinking.
Although there has been no dedicated study of Inter-
national Alliance for Responsible Drinking activity, it
directly replaced ICAP in maintaining connections
between researchers and alcohol companies in the
Moderate Alcohol and Cardiovascular Health trial,
which was terminated in 2018 due to inappropriate
relationships between National Institute on Alcohol
Abuse and Alcoholism employees, industry executives
and scientists, and a biased trial design [18].
Alcohol and tobacco companies are connected
through ownership and in other ways [19,20] and have
worked closely together to develop strategies to influ-
ence policy and deflect attention away from policies
that reduce profits [21]. The creation of the Founda-
tion for a Smoke-Free World in 2017, funded by
tobacco giant Philip Morris, has many of the hallmarks
of alcohol and tobacco CSR activity, including false
claims of independence and greater expenditure on
public relations activity than on scientific research
[22]. Yet, the Foundation for a Smoke-Free World has
struggled to recruit tobacco control researchers [22],
partly because of the close attention paid to tobacco
industry activity following the Master Settlement
Agreement in the USA in the late 1990s [23].
That enabled researchers to identify decades of manip-
ulation of science and policy, which involved the crea-
tion of front groups to cover up such activity [24,25].
The advent of electronic cigarettes has created new
opportunities for tobacco companies to divide the
research community that they have been keen to
exploit, with striking success [26,27]. This particular
initiative should be seen in this context. Nonetheless,
tobacco exceptionalism [28] and global health’s alco-
hol ‘blind spot’ [29] means the same critical lens is not
widely applied to alcohol industry CSR activity,
including alcohol industry SAOs [3]. As a result, alco-
hol industry SAOs have been able to recruit
researchers in ways that are no longer possible for
tobacco companies, although there are exceptions
[30], and this may be changing over time in light of
the revelations about tobacco and/or for other reasons.
There has been little dedicated study of alcohol
industry SAOs despite longstanding concerns about
SAO involvement in science, including the relationship
between researchers and SAOs [15,31–33]. We under-
took an interview study to address this gap, including
an exploration of researcher decision making regarding
working with these organisations.
Methods
We used a qualitative approach for this exploratory
study, underpinned by the science and technology
studies literature, where there is an acknowledgement
of the role of social interactions in constructing scien-
tific knowledge, and an interest in the values and
meanings researchers apply to their scientific work or
‘practice’ [31–33]. To give attention to both contem-
porary and historical experiences, we purposefully
sampled senior researchers globally. For this study, we
identified researchers who, once their career was
established, had received some form of payment
(including research funding, honorariums, and
expenses) from the alcohol industry or performed any
work (paid or unpaid) for any alcohol industry organi-
sation (n = 16). This study is nested within a larger
interview study of alcohol researchers (n = 37/44
invited). We report on researchers who received indus-
try research funding early in their careers and
researchers who had not worked with industry else-
where. The 16 researchers included in this study all
had either previous (n = 11) or ongoing (n = 5) con-
nections with SAOs, including social aspects func-
tions/committees of trade associations prior to the
formation of SAOs as distinct organisations [5] (n = 2)
and research funding organisations only (n = 2). The
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researchers worked on alcohol-policy relevant topics
across three continents, and their reflections dated
back to the 1960s. Although at the time of the inter-
view, the researchers were based in six countries, their
experiences also spanned other countries.
Semi-structured interviews were completed via video
or telephone; no significant differences were identified
between these modes of conducting the interviews in
terms of rapport building or the depth of responses to
the research questions. Interviews ranged from 40 to
75 min in total, averaging approximately 1 hour, with
one interview taking place in two parts. The first
author had experience of qualitative research inter-
viewing, including with experts, and conducted all
interviews. The second author listened to selected
audio recordings and provided feedback on interviews
throughout the data collection process. The interviews
began with career questions, followed by enquiries on
the formation of contacts with alcohol industry organi-
sations, factors informing their decision making, and
their perceptions of debates on the subject in the peer-
reviewed literature.
Data were analysed using a form of reflexive thematic
analysis [34,35], with each transcript read prior to initial
coding using NVivo software by the first author. Coding
developed iteratively rather than via a fixed codebook at
the start of the process, and themes were generated
alongside and subsequent to the coding. The first
author referred to the literature throughout to make
sense of the data [36], in particular, existing work on
ICAP and other alcohol industry SAOs [5,15,31,32].
The second author read the transcripts and supported
the first author throughout the analysis process.
The study received ethical approval from the
University of York Health Sciences Research Gover-
nance Committee. All participants gave their informed
consent prior to their inclusion in the study. We have
removed all identifying information about the partici-
pants from the quotes provided below, and do not use
pseudonyms to further protect researcher anonymity.
We have directly quoted 11 of the 16 researchers,
without relying heavily on any particular interviews for
this material.
Results
Contacts between researchers and SAOs were initiated
by both SAO employees and researchers’ colleagues.
Researchers were generally recruited for specific exper-
tise, with SAO employees inviting researchers to
apparently one-off events, and colleagues also involved
in inviting researchers into longer-term SAO advisory
roles. Awareness of risks associated with SAO roles
increased over time, as norms in the research commu-
nity changed gradually as concerns about commercial
interests corrupting science grew, both in relation to
tobacco and more widely. Thus, all researchers, with
one exception, were aware that there were inherent
risks, but viewed such work as an opportunity to reach
out beyond academia and improve public health. We
organise the presentation of findings on recruitment
sequentially, in line with the decision making and
other aspects of experiences recalled.
Initial recruitment
Among our 16 interviewees, a small number of key
individuals initiated contact between researchers and
SAOs. Seven researchers were recruited directly by
industry employees and eight indirectly by colleagues
with connections to SAOs (one did not provide this
information). For two of the seven researchers recruited
directly, this occurred in the 1980s or earlier, prior to
the formation of SAOs when industry employees invited
researchers to events. The remaining five researchers
were recruited directly since the 1990s by ‘revolving
door’ individuals—former academics who moved from
employment with governments, non-government orga-
nisation, or universities to become SAO employees,
sometimes retaining university affiliations. These indi-
viduals were small in number but highly influential,
using their extensive professional networks to recruit
researchers already known to them. Revolving door
individuals typically invited researchers to present at
SAO-organised events, or in the case of ICAP, write
book chapters for edited collections. Three of the five
researchers contacted in this way were approached by
the same person: a former World Health Organization
staff member who became the Director of ICAP. This
individual was well-known among researchers, and con-
tinued to attend scientific meetings.
Across our study, ICAP was reported to be a key
vehicle for recruiting researchers, although it was not
alone. Where contacted by researchers who represen-
ted other organisations, those individuals could be
persistent:
‘The first time [colleague] contacted me I said no, and
then [same colleague] contacted me again about six
months later saying that [the colleague and SAO] were
having a kind of think tank of a number of CEOs and
senior executives… and would I reconsider. So, I said yes.’
Indirect recruitment comprised requests from col-
leagues who held academic, clinical, or public health
posts and had connections to SAOs. These included
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requests to provide long-term expert advice for SAOs
via membership of scientific advisory committees or
board positions, or, occasionally, to present at SAO-
funded events. That the requests came from colleagues
was important: these were individuals researchers
trusted. Moreover, such colleagues could be leaders in
their field:
‘You don’t tend to turn things down if I think they’re
reasonable requests. And you certainly don’t tend to turn
things down if you are asked to do something by [well-
respected senior colleague].’
Researchers could then become part of the indirect
recruitment process themselves, when their own repu-
tations influenced the decision making of other
colleagues:
‘So I looked at the [group of researchers affiliated
with the SAO] and I thought, there [are] some people
who I think are very prestigious and honourable.’
In the rare cases where government departments
were deeply connected to SAOs, government involve-
ment validated the request. Occasionally, researchers
were recruited directly or indirectly by multiple SAOs
over the course of their career, although in most cases,
there was a relationship with a single organisation.
Weighing up potential risks and benefits
Reflecting on invitations prior to 1990 and the forma-
tion of SAOs as distinct organisations, researchers
reported that concerns around industry involvement in
science were not prominent, and thus the decision to
present at an industry-funded event was viewed, at the
time, as fairly unproblematic. Later, decision making
was usually more complex, and some researchers
explicitly acknowledged and discussed the risks
involved in accepting a request that would connect
them to an SAO. Industry actors could reap reputa-
tional, political, or commercial benefits from an associ-
ation, including to help better understand the research
community:
‘I know what their agenda was… I mean, they were try-
ing to suss out whether I’d help them. And they were
trying to pick my brains for what was going on, and they
wanted to get a sense of our views and positions on
things, which would help them strategically.’
Balanced against risks such as these, there was a
strong motivation to apply their knowledge beyond
academia, largely for the purpose of improving public
health. This was combined with a pragmatic perspec-
tive on the alcohol industry itself: researchers thought
industry involvement in any public health-related activ-
ity was not ideal, but as resources were limited, SAOs
might help plug gaps in provision.
In addition, researchers recognised the importance
of being confident that they could maintain their own
independence:
‘There may be a few bad apples here and there and I’m
sure there are, but there’s not a pharma, or anyone else,
who could alter my decision-making in terms of what’s
good for my patients and I think 99 percent of people are
like that.’
Because there were intricacies in the decision mak-
ing of researchers, they foresaw the need to review
their situation:
‘I accepted the position thoughtfully, and I think not
naively, and I always realised that this was something
that I would have to review myself, periodically.’
Short-term connections
Short-term connections were initiated by SAO
employees in two ways: inviting researchers to attend
events and, in the case of ICAP, to write one or more
book chapters. Regarding the latter, ICAP employees
suggested the topic, and researchers often wrote chap-
ters with colleagues, receiving a small honorarium for
their work. Researchers did not experience censorship
in their writing, although at times there was an
exchange between authors and ICAP employees:
‘No-one ever said, why are you saying this, or why don’t
you think about that? They didn’t. They engaged with
the other academics in a kind of critical discussion of
things that we wrote, but just what you would expect
from colleagues.’
Regarding events, researchers were invited to SAO-
funded, invitation-only events connecting researchers,
SAOs, and global alcohol producers. Occasionally,
researchers were invited to such events by their col-
leagues. Researchers regularly received invitations to
speak at non-industry organised events by a range of
different stakeholders, and in most cases knowing the
person inviting them made such requests appear
innocuous. There were also indications of curiosity
and hopes of influence:
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‘I perceived it as an important opportunity… with some
tough public health input you could influence… not just
the [SAO] but some of the surrounding people.’
Events ranged from small meetings on alcohol com-
pany premises, to slightly larger events with sessions
arranged according to topics. In most cases, researcher
expenses were paid and they were invited to speak on a
subject closely aligned with their area of expertise. In
earlier decades, researchers reported negative experi-
ences of such events, including being part of debates
where their views were in the minority:
‘I think I was kind of a lamb to the slaughter [laughs].
I was giving a talk to a very hostile kind of audience
who didn’t share my view of things.’
More recently, a feature of some events was an effort
to develop common positions between SAOs and
researchers:
‘I was really struck by the efforts of [the SAO] to get a
consensus agreement which [the SAO] wanted to write
[with] public health people and the industry support.’
Accepting invitations to such events could have
unforeseen consequences for researcher reputations:
‘On the first evening, we were all rounded up… all the
speakers… there was this photo taken of us… it was all
over the internet in moments.’
Attendance at one event usually led to further atten-
dance at one or more SAO events, largely with the
same organisation. Researcher experiences of these
events affected whether long-term connections
between SAOs and researchers were established. Some
researchers found industry attempts to promote con-
sensus between a SAO and researchers disingenuous,
or were disappointed that industry representatives did
not do what they said they would, and did not there-
fore develop long-term relationships with the SAO.
Other researchers established good relationships with
‘revolving door’ SAO employees who they regarded
highly. This led to the view that future work with the
SAO could be productive; these researchers went on
to establish long-term relationships with the SAO.
Longer-term connections
Ten of the 16 interviewees ultimately developed a
long-term relationship with the SAO with whom they
worked. These followed either positive short-term
connections described above, or indirect recruitment
by senior colleagues to these positions. These roles
largely comprised: (i) membership of scientific advi-
sory committees; (ii) trustee positions; and
(iii) independent consultancies and other dedicated
research-related roles.
1. Scientific advisory committees
Committee membership was either paid or unpaid,
and researchers were invited to join alongside other
research colleagues. Specific roles and types of advice
requested from researchers varied across organisation.
This could include reviewing and approving informa-
tion provided to the public, for example, which could
be time consuming:
‘The [SAO] was commissioning writers to write articles
based on the topics that we suggested and with the papers
that we highlighted for them to use. And what came
back, to some extent completely appropriately, was stuff
that was health literacy language level appropriate for a
broad region… so I realised that actually we were in
a very delicate situation around language. A lot of things
came back to me that I wasn’t happy with… and so we
got into quite a lot of discussion. I mean, it took a lot of
my time actually initially trying to get them to engage
with the issue… I don’t think this was the alcohol indus-
try trying to stealthily creep in to what we were writing. I
think it was a genuine dilemma.’
Other roles involved providing feedback on the stra-
tegic direction of the SAO, including potential SAO
research activity:
‘[SAO] just asked us about what sort of research might
they be able to become involved in and fund, if
anything—they weren’t offering us any money—and
what could they do to perhaps put their case forward so
that they were accepted as not as sort of biased as every-
one says they are.’
Researchers also carried out reviews on behalf of SAOs
on topics that did not conflict with commercial interests
or, when involved with research funding organisations,
reviewed grant applications. As committee members,
researchers usually did not have direct contacts with
SAO funders, although senior SAO employees were pre-
sent at committee meetings. Where researchers chaired
advisory committees, they had more contact with SAO
employees and funders, and were asked to report regu-
larly on committee activity, including being invited to
participate in SAO board discussions.
SAO advisory committee memberships lasted several
years and continued through organisational changes
(the move from ICAP to International Alliance for
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Responsible Drinking, for example). Researchers usu-
ally did not experience any industry interference in
committee decision making; rather, they described
straightforward relationships between researchers and
SAO employees:
‘[SAO employees] that I’ve worked with over recent
years are just grateful for advice and know the
boundaries.’
In the rare cases where interference in scientific pro-
cesses did occur, researchers resisted such efforts.
2. Board memberships
Other researchers were SAO trustees, working
alongside colleagues in public health, SAO personnel,
and senior company and trade association employees.
At least on one occasion, when researchers were inter-
viewed for the position, there was global alcohol pro-
ducer representation on the interview panel. Trustee
positions were typically unpaid and involved meeting
face-to-face several times a year, with extensive contacts
with senior industry representatives; this enabled
researchers to get to know industry representatives well.
Strategic decisions about the aims and purposes of
SAOs were made with fellow trustees. Other activities
undertaken included assisting with public health mes-
saging and reviewing grant applications. Researchers
acted as trustees for several years. Some aspects of the
role could be enjoyable, with researchers gaining a bet-
ter understanding of the alcohol industry from their
contact with industry representatives. However,
although researchers felt their individual relationships
with fellow trustees were appropriate, challenges arose
in terms of managing the combination of industry and
non-industry interests in seeking to contribute to pub-
lic health, for some from the start:
‘It was a challenge from start to finish. It was like wad-
ing through treacle. And every meeting entailed a robust
conversation with my fellow trustees.’
For others, these challenges developed gradually
over time, and the hopes that had motivated their orig-
inal involvement gave way to disappointment:
‘As time went by it became clear that [the industry
trustees] wanted to make the major decisions being
made by [the SAO]… I don’t think an awful lot of
value came from the [SAO] initiatives in terms of
bettering population health.’
3. Independent consultancies and other research-related
roles
Independent consultancies for SAOs, where
researchers were paid to provide expert advice on spe-
cific projects or activities, were rare in comparison with
other roles. In such work, senior SAO and alcohol
company employees asked questions, to which
researchers responded via email, phone, and in-person.
Researchers gained valuable insight into the structure
and activity of SAOs and global alcohol producers, but
the industry response to their advice was mixed:
‘I mean it really varies. [On technical, smaller mat-
ters]… yes, they have listened. On the big public health
issues I would say no.’
Some researchers also received SAO research
funding, although this was not strongly implicated in
other specific roles examined here, and was facilitated
by existing relationships; for example, project grant
funding availability was not advertised. In these cases,
reliance on soft money was very relevant to decision
making. These researchers did not experience industry
censorship, although in some cases interventions were
designed by the SAOs with a lack of scientific input at
that stage, with the research role confined to that of
evaluation. Involvement in SAO-funded studies was
preceded by, and also sometimes led to further direct
contacts with SAO employees and their funders at
SAO-funded events relating to the study.
Researcher reflections. Reflecting on their relationships
with the alcohol industry, most researchers we inter-
viewed had changed their minds about the wisdom of
their involvements, and ended their associations, even
relatively trivial ones:
‘I had the view that research can be presented pretty
much anywhere. I subsequently sort of revised that
scheme somewhat and I really am not keen on presenting
at industry-specific events or anything… I’ve evolved I
guess you might say.’
For many, this was because of negative experiences
and some regretted that they had not had access to suf-
ficient information or guidance to make an informed
decision at the time:
‘I think probably if somebody with a little bit more expe-
rience who was a little bit wiser had had that conversa-
tion with me at that time I probably would have thought
twice about taking on that role with [an SAO] to
begin with.’
Negative responses from colleagues about
researchers’ connection to industry were common,
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particularly after ICAP became controversial within
the research community. They were also reported as
having adverse career impacts, at times leading to
fewer academic opportunities, as one researcher
summed it up starkly:
‘It was terrible for my career.’
Others, particularly when reflecting on longer-term
changes, were of the view that as the wider research
community became more sceptical of industry activity,
this influenced their decision making. Researchers
reflecting on ongoing work had not yet come to any
conclusion about how productive the link with SAOs
would be, or valued it.
All researcher decision making and retrospection
were communicated in ways that valued integrity.
Regardless of whether their decision making had
changed, a sense of rejection by colleagues had strong
personal impacts:
‘I remember [losing academic opportunity] was one of
the most difficult, personal blows because I felt it was a
vote of lack of confidence in me as an individual and my
integrity, and that’s very important to all of us and
hugely important to me all the way through my career.
And that was personally very, very hurtful.’
Just as many had changed their minds about their
own involvements, 11 of the 16 researchers urged
junior colleagues to avoid any connection to industry:
‘Honestly, I think for early career researchers, I would
probably recommend not to do it, mainly because of the
problems it might cause with colleagues and relationships
down the road.’
Two were equivocal, seeing many risks and also cir-
cumstances in which they might be accepted, while the
remaining three researchers reflected largely positively
on their experiences, which sustained them in relation-
ships with the same SAO, or led to interactions with
multiple industry bodies, including industry research
funding organisations and alcohol companies.
Discussion
By exploring researcher reflections on both previous
and ongoing connections to SAOs, we identify the key
roles both currently established and former researchers
have played in initiating and maintaining SAO-
researcher connections. Most researchers reflected
negatively on their experiences, although some had
positive experiences. Of the factors informing
researcher decisions to accept SAO-linked invitations,
motivations to ‘reach out’ beyond academia to
improve public health and the limited resources avail-
able for this are particularly significant. These connec-
tions provide SAOs with significant public relations
opportunities, helping the SAOs to present themselves
as independent, public interest groups working in
‘partnership’ with public health organisations and
researchers [7].
A small number of ‘revolving door’ individuals—
researchers who had moved from academic, government,
or non-governmental organisation positions to become
SAO employees—recruited many of the researchers
interviewed, and not only to ICAP. Concerns have been
raised about such practices [31,32], and this first qualita-
tive interview study of this topic highlights what a crucial
role a small number of individuals have played in initiat-
ing connections between researchers and SAOs. This is a
small sample, with reflections spanning some decades.
The second author’s research on the alcohol industry
may have influenced the range of experiences shared by
participants, although the high response rate and the
depth of the data suggest this was not obviously problem-
atic. Interview accounts engender risks of inaccuracy and
recall bias, particularly in relation to the distant past in
the context of changing norms. It is important to note,
however, that not all reflections were historical: five of
the researchers were reflecting on ongoing connections
to SAOs, therefore, this is a contemporary concern as
well as a historical one.
The key mechanism here appears to be trust:
researchers trusted colleagues they had worked with
previously whether they were recruited directly or indi-
rectly, and focused on them as individuals rather than
the organisations they represented. Trust is, in part,
built reflexively, emerging in specific conditions through
social interactions [37]. Combinations of revolving door
individuals, already involved academic colleagues, and
interpersonal contacts at events can create conditions in
which researchers are willing to make a ‘leap of faith’
[37]. This was necessary here because there were obvi-
ous risks involved, and guidance and evidence on SAOs
were scarce. Researchers, of course, also make decisions
to work with individuals they trust where the alcohol
industry is not involved. Such decisions, however, are
not made in a vacuum, and the contrast with the
tobacco industry is stark [22,38].
The extensive opportunities for SAO employees to
develop and widely publicise connections with established
researchers may impact on the decision making of junior
colleagues in relation to involvement with industry. This
may have given junior researchers the impression that
work with SAOs was unproblematic, creating a ‘cycle of
legitimacy’ that excludes a crucial conclusion now
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available: that most researchers had negative experiences,
would not repeat them, or advise early-career colleagues
to follow them. In this way, our data add to existing
research demonstrating SAO activity does not contribute
to public health goals [5]. Rather, senior researchers’
experiences of apparently ‘one–off’ industry-funded events
reflect broader patterns of SAO scientific activity, includ-
ing initiatives such as ICAP’s Dublin Principles [16],
which explicitly sought to build industry-researcher part-
nerships, as well as sharing commonalities with strategies
used by other sectors, such as the ultra-processed foods
industry [39,40].
Scientific norms have been exploited by SAOs, and
the imperative for alcohol and other research to generate
societal impact permeates most stages of the scientific
endeavour. Work with SAOs was attractive to
researchers in part because of the low level of resources
available to public health actors to provide good quality
information to the public about alcohol. For a small
number of researchers, the experience of communicating
with the public was mostly positive, and the only nega-
tive was the reactions from colleagues, which may have
led to lost opportunities. Based on the evidence pro-
vided here, where the majority of researchers reported a
lack of progress towards public health goals when work-
ing with SAOs, as well as growing evidence on the
misinformation provided to the public by SAOs in vari-
ous countries [6–8], we suggest negative responses from
colleagues should be interpreted as a symptom of the
underlying conflict between public health interests and
alcohol industry interests manifested in SAO activity.
There has been rapid concentration in recent decades
with a small number of transnational alcohol producers
capturing most of the global market, particularly for
beer and spirits [41]. The resources this generates for
these companies may lead the alcohol industry to more
closely resemble the tobacco industry, both in structure
and in strategy [3]. More research is required on both
the mechanisms and consequences of researcher rela-
tionships with SAOs, including with the International
Alliance for Responsible drinking, ICAP’s direct succes-
sor. This may help preserve the integrity of science, as
well as facilitate the communication of alcohol research
and other information to the public, by organisations
acting in the public interest.
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